Results 71 to 80 of about 12,269 (257)

Wearable Flexible Phototherapy Device for Knee Osteoarthritis

, 2021
Knee osteoarthritis (OA) is a highly prevalent and disabling disease that causes pain and gradual degeneration of the articular cartilage. Phototherapy is a new physiotherapy treatment, more effective and stable than other non-pharmacologic management ...
Hongda Chen, Kun Liu, Mengqi Wang, Yuguang Wang, Jun Tang   +4 more
core   +1 more source

A COMPARATIVE STUDY OF RATE OF FALL OF TOTAL SERUM BILIRUBIN IN JAUNDICED BABIES FOLLOWING CONTINUOUS AND INTERMITTENT PHOTOTHERAPY

Journal of Nepal Medical Association, 2003
Jaundice is observed during the first week of life in approximately 60% of term infants and 80% of preterm infants.1 Out of the 60% only 5% term and 20% preterm actually need treatment2 like phototherapy.
Bhubanesh Kumar Bhatta, P S Shrestha
doaj   +1 more source

Mirror covered tunnel phototherapy increases the efficacy of phototherapy for neonatal jaundice [PDF]

Objective: Neonatal jaundice (NJ) is one of the most common cause of neonatal hospital admission. Phototherapy is the main therapy for hyperbilirubinemia of neonatal jaundice. The efficacy of phototherapy depends on the dose and wavelength of light used
امینی ثانی, نیره, شمشیرگران, سید مرتضی, صالح زاده, فرهاد, میرزا رحیمی, مهرداد, جهانگیری, سپیده, شرقی, افشان, حبیب زاده, شهرام   +6 more
core  

Home phototherapy in vitiligo

, 2017
Vitiligo is a disorder characterized by the development of depigmented macules and patches. Narrowband ultraviolet B phototherapy is a standard of care treatment and is used both as monotherapy and in combination with other treatment modalities to induce
Narumol Silpa-Archa, Iltefat H. Hamzavi, Silpa-Archa, Narumol, Henry W. Lim, James L. Griffith, Mohammad, Tasneem F, Hamzavi, Iltefat H, Lim, Henry W, Griffith, James L, Tasneem F. Mohammad   +9 more
core   +1 more source

Phototherapy trends in dermatology 2015–2018

, 2022
Background Trends in phototherapy utilization including its main clinical indications were last characterized by Luersen et al. for the time period of 1997–2010.
Sogol S. Javadi, Jashin J. Wu, Aislyn Oulee, Amylee Martin, Tran Do   +4 more
core   +1 more source

Effects of LED phototherapy on oxidative damage in hyperbilirubinemia neonates

BMC Pediatrics
Background Phototherapy is known to cause oxidative damage in neonates, there is no research on DNA damage repair before and after phototherapy in hyperbilirubinemia neonates at present.
Meihong Gu, Lifang Lin, Tianming Yuan
doaj   +1 more source

Stereocomplex Crystallized Nanomedical System for Enhanced Type I PDT and Synergistic Chemo-Phototherapy

Photodynamic therapy (PDT) is one of the promising approaches for tumor treatment. Although PDT offers many advantages, it is still challenged by the restriction of oxygen and the defense system of tumors.
Haifeng Chen (1425637), Lan Mei (5518391), Gang Guo (146383), Bo Chen (32294), Yangmei Ren (6038138), Cheng Huang (115619), Aiping Tong (2279449), Rangrang Fan (6038141), Chao Wang (146527)   +8 more
core   +1 more source

Effect of phototherapy on serum calcium levels in neonates receiving phototherapy for neonatal jaundice

, 2018
Background: To study the occurrence of hypocalcaemia in neonates with physiological unconjugated hyperbilirubinemia after 48 hours of phototherapy or at the end of phototherapy, in case duration of phototherapy was less than 48 hours.Methods: This ...
Anshuman Srivastava, Goyal, Sumit, Sumit Goyal, Isha Goyal, Srivastava, Anshuman, Malhotra, Khushbu, Bhattacharjee, Prasun, Khushbu Malhotra, Prasun Bhattacharjee, Goyal, Isha   +9 more
core   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability

, 2016
Benjamin Farahnik,1 Viraat Patel,2 Kourosh Beroukhim,3 Tian Hao Zhu,4 Michael Abrouk,2 Mio Nakamura,5 Rasnik Singh,3 Kristina Lee,5 Tina Bhutani,5 John Koo5 1University of Vermont College of Medicine, Burlington, VT; 2School of Medicine, University of ...
Koo J, Nakamura M, Beroukhim K, Farahnik B, Lee K, Patel V, Abrouk M, Singh R, Zhu TH, Bhutani T   +9 more
core